Please login to the form below

Wilmington Healthcare

A heritage to envy

Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS and Wellards to create an unrivalled healthcare data, education and information resource with outstanding analytics capabilities. Binley's is a healthcare data and intelligence provider, which translates the complex NHS environment into useful information that helps organisations to increase sales, save money and improve healthcare. NHiS was founded in 2007 in response to a growing need in the marketplace for quantitative and qualitative data to inform service redesign and pathway efficiencies. Wellards provides the most up-to-date and comprehensive NHS information and training on the market.

What do we do?

Our close connections across the healthcare community, coupled with our high-quality data assets result in effective and actionable insights for our clients. We offer unrivalled expertise in:

In depth local UK healthcare knowledge
Close relationships with, and proximity to, the NHS
The largest collection of data assets in the UK
Customised intelligence
Service redesign
Industry standard-setting unique learning platform

How do we work?

We understand our customers’ requirements, no matter how complex they may be. Our team is skilled at tailoring the right solutions and supporting this journey every step of the way: from supplying data and insight, to engagement opportunities with stakeholders and health sector thought leaders. We will work closely with you to ensure you have the solution that meets your needs.

What results do we get?

Wilmington Healthcare aims to be your data and insight partner. We will provide you with the intelligence you need to transform outcomes for patients and your organisation. Through working with Wilmington Healthcare, our clients develop expertise in their area of focus, helping them to not only gain traction in the market but to achieve market-leading positions and the results to match.

Areas of Expertise

Health data, analytics and insight
Education
Engagement and collaboration
Data, market insight and marketing services
NHS service transformation

Press Releases

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW: Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this latest quick-read briefing, Oli Hudson, Content Director at Wilmington Healthcare, lifts the veil on what place is, how it works and why it matters.
MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE: With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is it responding to this challenge, and what can industry do to support it? Oli Hudson, Content Director at Wilmington Healthcare, explains what’s changing and how industry should respond.
ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS: With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes and why they matter for pharma and med-tech companies.
HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW: Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to the NHS and its prescribing behaviours during the peak of the pandemic. Oli Hudson summarises five of the key findings:
ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE: With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.
Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed
EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES: As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its part.
UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS: Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected across all brand planning and engagement activity.
Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool: Paul Rowe to lead intelligence tool that allows Industry to gain the complete picture of their changing NHS customer base and employ precision planning to access target customers and markets.
LOOKING AHEAD: UNDERSTANDING THE NHS CUSTOMER’S PRIORITIES FOR 2022/23: The recently published operational planning guidance describes what the NHS needs to achieve this year. Wilmington Healthcare’s Oli Hudson explores some of its critical themes and what they mean for industry.
NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE: With a stormy outlook predicted for health and care, Wilmington Healthcare’s Oli Hudson looks at the five critical shifts that pharma should focus on as it navigates its way through 2022.
CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE: As well as creating new structures, the reforms underway within the NHS will see a considerable movement of people and power across the new Integrated Care Systems. Wilmington Healthcare’s Victoria Paxman looks at how the landscape of key influencers and decision-makers will change as a result.
We must be candid about our use of healthcare data if we want to win back public trust: As the government announces a delay to a new GP data sharing initiative amid privacy concerns, Gareth Thomas, Managing Director of Wilmington Healthcare, explains why industry must move fast to rebuild public confidence.
Wilmington Healthcare appoints new Solutions Director: Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare
Understanding the role of provider collaboratives: Oli Hudson, Content Director at Wilmington Healthcare, takes a look at the new groups of providers that are expected to play a pivotal role in integrating care.
Wilmington Healthcare launches new platform to map the formulary landscape: Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.
Wilmington Healthcare appoints new Head of Digital
How has the pandemic reshaped the NHS in 2020?: Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.
White paper helps industry navigate new NHS roadmap: New report shows how pharma can support the NHS in the Covid-19 recovery era
2019: A pivotal year for the NHS: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the key changes in the NHS in 2019
Wilmington Healthcare appoints new consultants: Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants - Roger Tomlins and Sarah Shield.
Wilmington Healthcare makes new senior appointment: Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has appointed Jonathan Carney as Director of its Insight and Key Account Management (KAM) services.
Winners of the HSJ Partnership Awards 2019 unveiled: The winners of the HSJ Partnership Awards 2019 were announced on 20 March at a prestigious black-tie awards ceremony at Park Plaza, Westminster.
HSJ Partnership Awards 2019 shortlist announced: The finalists for the HSJ Partnership Awards have been announced today ahead of a prestigious black-tie dinner awards ceremony at Park Plaza, Westminster Bridge on 20 March 2019.
Healthcare excellence celebrated at 2018 HSJ Awards: Thousands of healthcare professionals were in attendance, all eager to scoop one of the coveted prizes from the world’s largest healthcare awards programme.
Wilmington Healthcare adds innovative new features to its digital learning platform for pharma and medtech: Healthcare intelligence provider Wilmington Healthcare has introduced a host of new features to its unique digital learning platform, which enables pharma and medtech sales staff to keep abreast of NHS developments, policies and constraints.
HSJ Awards Finalists Announced: 2018 HSJ Awards Finalists Announced.
HSJ Partnership Awards will showcase pharma’s inspirational joint working projects with the NHS: Health Service Journal (HSJ), the news and information service for all healthcare leaders working in, for, or with the NHS, has expanded and enhanced its Partnership Awards for 2019.
Wilmington Healthcare wins first client for new NHS transformation tracker: Product helps pharma identify opportunities and tailor solutions to a changing NHS
Wilmington Healthcare appoints new Commercial Director: Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.
Sir Bruce Keogh is appointed chair of judges for HSJ Awards: Sir Bruce Keogh, the former National Medical Director for NHS England, will chair the judges’ panel for the 37th annual HSJ Awards – the world’s largest healthcare awards programme.
HSJ Awards open for entry with promise to champion NHS on its 70th anniversary: HSJ Awards open for entry with promise to champion NHS on its 70th anniversary
Wilmington Healthcare survey finds many doctors fear the NHS will fall victim to another ransomware attack: Following the ransomware attack that wreaked havoc on NHS IT systems last year and resulted in major disruption to patient care, the majority of doctors surveyed by healthcare intelligence provider Wilmington Healthcare say they believe another attack is likely.
Innovative NHS suppliers scoop HSJ Partnership Awards: Winners include pharma, medtech, healthcare consultants and IT specialists. Innovative pharma and medtech companies have been honoured in an awards scheme run by Health Service Journal (HSJ), the news and information service for all healthcare leaders working in, for, or with the NHS.
Leading NHS suppliers highlighted in shortlist for new HSJ awards
Wilmington Healthcare makes new senior appointment
Wilmington Healthcare appoints new Account Director: Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.
Launch of the HSJ Partnership Awards: a programme for inspirational organisations helping to transform the NHS: New Awards will recognise the many private sector organisations who partner with the NHS to deliver improved patient outcomes and cost-effective care
New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise: Updated data published by Wilmington Healthcare and the MS Trust highlights need for more preventative care for MS patients
Wilmington Healthcare launches new, integrated, digital channel to help pharma engage with the NHS
New report shows Traumatic Brain Injury (TBI) is a major threat to older people

White Papers and Resources

How does the government plan to reshape the NHS?: Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care
Integrated NHS finances: what do they mean for High Cost Drugs?: Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs
Covid-19: how is it affecting prescribing patterns?: Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas
Harness the power of data to map new patient pathways: Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
How can pharma align its brand strategy with the NHS Reset?: Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era
Covid-19 redefines rules of customer engagement: Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs
Covid-19 drives change in long-term conditions management: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home
Covid-19: how is it impacting on the NHS Long-term Plan?: Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy
Covid-19: what could it mean for the diabetic population?: Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it
Delivering true value: what does it mean for KAM in cancer care?: Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond
Early diagnosis underpins NHS cancer strategy: Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan
What is changing in cardiovascular disease care?: Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma
What is changing in mental health and dementia care?: Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published
A new vision for tackling key illnesses: Steve How and Oli Hudson, of Wilmington Healthcare, explore the NHS Long-term Plan’s strategy for delivering more preventative, joined-up services for major health conditions
Spotlight on innovation at life sciences forum: Paul Midgley, of Wilmington Healthcare, takes a look at the forthcoming HSJ Life Sciences Forum, where the NHS and industry will unite to discuss challenges and explore innovative solutions
GPs will play a pivotal role in integrated care: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explain how the new GP contract will shape local joined-up systems
What role for pharma in helping to deliver integrated care?: Steve How and Paul Midgley, of Wilmington Healthcare, explore how pharma can support local health economies in providing joined-up, holistic services
Putting disease prevention on a par with cure: Steve How and Paul Midgley, of the Wilmington Healthcare Consulting Team, explore how the NHS is taking an increasingly holistic approach to care
What does the new NHS plan mean for pharma?: Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of the NHS Long-term Plan
NHS medicines optimisation milestone: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry
New local NHS models help to deliver integrated care: Steve How, of Wilmington Healthcare, explains how health and social care groups are uniting within ‘neighbourhoods’
How can pharma engage with key stakeholders on NHS service transformation?: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change
How can pharma support NHS service change?: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, find some answers in NHS England guidance for commissioners
How will new data protection law affect pharma?: Sarah Eglington, of Wilmington Healthcare, explores how GDPR will change pharma’s relationship with healthcare professionals
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare
How can pharma engage with key decision-makers in new, collaborative NHS care models?: Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach
Managing local population needs is key for the NHS: Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma
Large-scale NHS commissioning models require new partnership approach from pharma: Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working
Shining a light on the true cost of patient care: Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS
How can pharma engage with the top performing STPs?
What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?: Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach
How will the NHS’s new medicines savings drive affect pharma?: Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets
How can pharma help the NHS capitalise on its data?: Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services
How can pharma engage with Accountable Care Systems?: Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain how pharma can add value across care pathways
How will capitated budgets affect NHS spending?: Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?: Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma
How will Sustainability and Transformation Plans (STPs) change the NHS in 2017?: Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the impact that STPs will have on the NHS and what this means for pharma.
How can pharma help the NHS drive much-needed change in mental health services?: Laurence Mascarenhas, of Wilmington Healthcare, assesses how pharma can help the NHS to achieve Parity of Esteem (PoE) in mental health
How can the NHS deliver integrated care?: Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain the changes needed to help the NHS provide a more holistic, joined up experience for patients
How can pharma engage with NHS Vanguards?: Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.
What does the Five Year Forward View mean for pharma?: Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.

Latest Tweets

Tweets by @WilmHealthcare

Testimonials

"High accuracy data, straight-forward customer service and instructions, and a smooth overall experience."
Christos Begkos, University of Manchester

"Service redesign provided us with development of integrated, person-centred care and greater focus on proactive management of the neurology patients most in need of care."
CCG Commissioning Lead

"By having jointly agreed guidelines and processes for what are complex - and often confusing - arrangements, it will simplify the system for professionals, as well as patients and carers."
Marilyn Ekers, Acting Chair of North Yorkshire and York Neurological Alliance

Company Details